Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Propensity-matched Comparison of VATS Left Upper Trisegmentectomy and Lobectomy.

The Annals of thoracic surgery·2021
Same author

Interrogation of the dynamic properties of higher-order heterochromatin using CRISPR-dCas9.

Molecular cell·2021
Same author

MicroRNA-20a Targeting LASS2 Promotes the Proliferation, Invasiveness and Migration of Bladder Cancer.

Clinical laboratory·2021
Same author

Quantitative MR relaxation using MR fingerprinting with fractional-order signal evolution.

Journal of magnetic resonance (San Diego, Calif. : 1997)·2021
Same author

Application of a decision tree model in the early identification of severe patients with severe fever with thrombocytopenia syndrome.

PloS one·2021
Same author

Haplotype-resolved genome assembly provides insights into evolutionary history of the tea plant Camellia sinensis.

Nature genetics·2021

相关实验视频

Updated: Jan 18, 2026

Enhancing Tumor Content through Tumor Macrodissection
10:04

Enhancing Tumor Content through Tumor Macrodissection

Published on: February 12, 2022

12.1K

主要膀扩散大B细胞淋巴瘤:一个罕见的病例报告.

Haole Xu1, Wei Feng1, Hongjin Shi1

  • 1Department of Urology, The Second Affiliated Hospital, Kunming Medical University, Yunnan Province, China.

International journal of surgery case reports
|September 9, 2025
PubMed
概括
此摘要是机器生成的。

主要膀扩散大B细胞淋巴瘤 (DLBCL) 是罕见的,并模仿常规的膀癌. 确定的诊断需要免疫组织化学,治疗不同于泌尿腺癌,涉及R-CHOP化疗.

关键词:
化疗 化疗是一种化学疗法.扩散性大B细胞淋巴瘤 (DLBCL)恶性膀瘤是一个恶性膀瘤.非霍奇金淋巴瘤 (NHL) 是一种非霍奇金淋巴瘤.进行激进的囊切除术.

更多相关视频

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

21.7K
Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma
10:52

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on: March 30, 2018

11.6K

相关实验视频

Last Updated: Jan 18, 2026

Enhancing Tumor Content through Tumor Macrodissection
10:04

Enhancing Tumor Content through Tumor Macrodissection

Published on: February 12, 2022

12.1K
Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
11:02

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on: October 30, 2013

21.7K
Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma
10:52

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on: March 30, 2018

11.6K

科学领域:

  • 尿瘤学 尿瘤学
  • 血液性恶性瘤 血液性恶性瘤
  • 病理学 病理学 病理学

背景情况:

  • 扩散性大B细胞淋巴瘤 (DLBCL) 是一种常见的非霍奇金淋巴瘤 (NHL),通常起源于淋巴结.
  • 主要膀DLBCL异常罕见,原因是膀中没有淋巴组织.

研究的目的:

  • 报告一种罕见的初级膀DLBCL病例.
  • 为了突出诊断和管理的挑战,膀DLBCL.

主要方法:

  • 一个83岁的男性患有膀质量的病例报告.
  • 通过病理学和免疫组织化学检查证实了诊断.
  • 患者接受了急性囊切除术,并计划接受R-CHOP化疗.

主要成果:

  • 膀质被病理诊断为DLBCL,最初怀疑是腺囊炎.
  • 临床表现和常规成像 (CT/MRI) 并没有确定.
  • 患者在术后一个月因疾病进展而死亡.

结论:

  • 膀质量可能源自淋巴组织,可能被误诊.
  • 免疫组织化学对于确定膀DLBCL的诊断至关重要.
  • 膀DLBCL的治疗不同于泌尿腺癌,需要像R-CHOP一样的化疗.